[The effect of mycoplasma infection on the reproduction of various RNA-containing viruses].

PubWeight™: 0.76‹?›

🔗 View Article (PMID 5629348)

Published in Vopr Virusol on May 25, 1969

Authors

R Ia Kagan, F I Ershov, I V Rakovskaia, A A Tsareva, V M Zhdanov

Articles citing this

Mycoplasmas and cell cultures. Bacteriol Rev (1971) 2.41

Articles by these authors

(truncated to the top 100)

Integration of viral genomes. Nature (1975) 1.45

Return of epidemic A1 (H1N1) influenza virus. Lancet (1978) 1.38

Infectious DNA of tick-borne encephalitis virus. Arch Gesamte Virusforsch (1974) 1.15

Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine. Nature (1968) 1.15

Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J Gen Virol (1986) 1.14

Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice. Virology (1984) 1.11

Integration of measles virus nucleic acid into the cell genome. Arch Gesamte Virusforsch (1974) 1.08

Morphogenesis of Venezuelan equine encephalomyelitis virus. J Virol (1969) 1.06

Combined action of ribovirin and rimantadine in experimental myxovirus infection. Experientia (1977) 1.05

Mason-Pfizer virus characterization: a similar virus in a human amniotic cell line. J Virol (1973) 1.03

Influence of PPLO on production of interferon in virus-infected cells. Virology (1965) 0.97

On the origin of the H1N1 (A/USSR/90/77) influenza virus. J Gen Virol (1981) 0.97

Architecture of Venezuelan equine encephalomyelitis virus. Virology (1965) 0.96

The 1967 outbreak of influenza B in the U.S.S. R. Lancet (1967) 0.96

Ex vivo screening of prospective peptide drugs: new approaches. Dokl Biol Sci (2010) 0.94

Studies on the genetic determinants of influenza virus pathogenicity for mice with the use of reassortants between mouse-adapted and non-adapted variants of the same virus strain. Arch Virol (1986) 0.93

The 1965 influenza A2 epidemic in the USSR and antigenic analysis of isolated strains. Am J Epidemiol (1967) 0.93

HeLa-like marker chromosomes and type-A variant glucose-6-phosphate dehydrogenase isoenzyme in human cell cultures producing Mason-Pfizer monkey virus-like particles. J Natl Cancer Inst (1974) 0.92

Biophysical characteristics of respiratory syncytial virus. Rev Roum Virol (1974) 0.92

Use of iodinized antibody for revealing viral antigens in ultra-thin sections of cells. Nature (1965) 0.91

[Characteristics of the molecular organization of bacteriophage T4 whiskers]. Dokl Akad Nauk SSSR (1987) 0.91

[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.90

[Antiviral activity of immunomodulator Selank in experimental influenza infection]. Vopr Virusol (2009) 0.87

Synthesis and transport of protein components of Sendai Virus. Arch Gesamte Virusforsch (1965) 0.87

[Influence of environmental factors on the expression of Mycoplasma pneumoniae gene responsible for the synthesis of protein P1 adhesion]. Zh Mikrobiol Epidemiol Immunobiol (2003) 0.86

Isolation of oncornaviruses from continuous human cell cultures. Intervirology (1973) 0.86

[Replicative intermediate form of RNA in cells infected with Newcastle disease virus (NDV)]. Vopr Virusol (1972) 0.86

Ribonucleic acids synthesized in Venezuelan equine encephalomyelitis virus-infected cells. Virology (1969) 0.86

Antiviral properties of structural fragments of the peptide Selank. Dokl Biol Sci (2010) 0.85

Gradual changes of influenza virions during passage of undiluted material. J Gen Virol (1980) 0.85

Synthesis of components of Sendai virus in the presence of proflavine. J Immunol (1965) 0.85

Disulfide bonding in influenza virus proteins as revealed by polyacrylamide gel electrophoresis. J Virol (1982) 0.85

Molecular pathogenesis of systemic lupus erythematosus. Arch Virol (1975) 0.85

An unusual influenza situation in 1977-78. WHO Chron (1978) 0.85

Relationship between group A arbovirus reproduction and cytochemical changes in infected cells. Acta Virol (1968) 0.84

An oncornavirus isolated from human cancer cell line. Cancer (1973) 0.84

[The primary structure of the hemagglutinin of influenza A (H3N2) viruses isolated in the USSR in 1985]. Vopr Virusol (1989) 0.83

[Use of leukocyte cultures for studying cytomegalovirus infection in man]. Vopr Virusol (1969) 0.83

B-type oncornaviruses isolated from continuous human cancer cell lines. Arch Gesamte Virusforsch (1973) 0.83

Influenza virus antigens conjugated with a synthetic polyelectrolyte: a novel model of vaccines. Vaccine (1985) 0.83

[An interferon inhibitor in regulating the activity of human natural killer cells]. Biull Eksp Biol Med (1991) 0.82

Action of proflavine on the development of Sendai virus in HEp 2 cells. Br J Exp Pathol (1966) 0.82

[Integration of the genomes of the tick-borne encephalitis virus and of the cell in chronic infection due to this virus and SV40]. Dokl Akad Nauk SSSR (1981) 0.82

Results of a two-year study of humoral immunity to influenza A and B viruses in children under the age of 14 years in Moscow and its suburbs. Bull World Health Organ (1984) 0.81

[Intermolecular covalent (disulfide) bonds in the peplomers of influenza virus hemagglutinin]. Vopr Virusol (1983) 0.81

Topography and dynamics of synthesis of structural proteins of Newcastle disease virus. J Bacteriol (1966) 0.81

In vitro studies with the scrapie agent. Acta Virol (1985) 0.81

[The use of polyacrylamide gels in the study of Newcastle disease virus RNA]. Vopr Virusol (1969) 0.81

Antigenic determinants in influenza virus hemagglutinin. Infect Immun (1979) 0.81

Isolation of a natural recombinant of influenza A virus (H1N3) from a sick child. Lancet (1983) 0.81

Continuous mouse brain cell lines chronically infected with Japanese encephalitis virus. J Gen Virol (1974) 0.80

Formation of infectious arbovirus ribonucleoprotein in subcellular structures. Nature (1970) 0.80

[Role of Chlamydia, mycoplasma and cytomegalovirus infection in the development of coronary artery disease]. Kardiologiia (2003) 0.80

[Oncornavirus type B from human laryngeal carcinoma cells]. Vopr Virusol (1973) 0.80

The use of antibody labeled with an organic mercury compound in electron microscopy. J Histochem Cytochem (1966) 0.80

Isolation of a leukovirus from a continuous human cell line. Arch Gesamte Virusforsch (1972) 0.80

Russian experience in screening, analysis, and clinical application of novel interferon inducers. J Interferon Cytokine Res (2001) 0.80

Persistent SV5 virus infection in continuous cell cultures. Acta Virol (1976) 0.80

[Ani immunomodulator Hepon inhibits hepatitis C virus replication in human cell cultures in vitro]. Antibiot Khimioter (2002) 0.80

Integration of genomes on infectious viruses. Mol Cell Biochem (1977) 0.79

[Antigenic and biological characteristics of the A (H1N1) strains that caused the 1977--1978 epidemic]. Vopr Virusol (1980) 0.79

Photodynamic and fluorochromic properties of the antibiotic actinomycin D. J Cell Physiol (1965) 0.79

Virions released from the surface of leukovirus-producing cells. Arch Gesamte Virusforsch (1974) 0.79

[Mixed infection of mice of line BAL/B/CDE with Rauscher virus and Mycoplasma laidlawii]. Vopr Virusol (1975) 0.78

Phenotypic mixing of vesicular stomatitis virus and D-type oncornavirus. Int J Cancer (1976) 0.78

On the mechanism of the persistence of lymphocytic choriomeningitis virus in the continuous cell line Detroit-6. Intervirology (1978) 0.78

Intracellular virus-specific structures and RNAs in oncornavirus-producing human cells. J Virol (1974) 0.78

Production of an oncornavirus by the continuous human cell line, Detroit-6. J Natl Cancer Inst (1974) 0.78

[Synthesis of virus-induced interferon following exposure of cells to irradiation and chemical mutagens]. Dokl Akad Nauk SSSR (1977) 0.78

Antigenic changes in mouse-adapted influenza virus strains. Lancet (1983) 0.78

[Adhesion molecules expressed in vascular endothelial cells in natural immunity against viral infections]. Vestn Ross Akad Med Nauk (2011) 0.78

[Physicochemical properties of the RNA and proteins of an influenza virus H1N3 isolated from an ill child and antigenically analogous to A/whale/TO/19/76]. Vopr Virusol (1985) 0.78

Fate of Sendai virus ribonucleoprotein in virus-infected cells. J Virol (1969) 0.77

[Role of works of S. V. Prozorovskii in solving problems of persistence of wall-free forms of microorganisms]. Vestn Ross Akad Med Nauk (2001) 0.77

[Results of combined therapy using levamisole for patients with influenza complicated by pneumonia]. Vopr Virusol (1984) 0.77

Leukoplakia of oral mucosa: pathogenesis and possible correction with phytoadaptogen. Bull Exp Biol Med (2004) 0.77

[Lipid-associated membrane lipopeptides of M. arginini activate NF-kB by interacting with TLR2/1, TLR2/6, and TLR2/CD14]. Mol Gen Mikrobiol Virusol (2009) 0.77

Viruses as a factor of evolution: exchange of genetic information in the biosphere. Adv Virus Res (1974) 0.77

[Evaluation of the interferon status of human subjects by whole-blood specimens]. Vopr Virusol (1989) 0.77

[Correlation between activity of the phosphoenol-pyruvate-dependable phosphotransferase system (PTS) and synthesis of adhesion P1 protein in Mycoplasma pneumoniae]. Mol Gen Mikrobiol Virusol (2003) 0.77

[The endogenous regulation of the cytokine disbalance in humans subjected to simulated spaceflight environment]. Vestn Ross Akad Med Nauk (2006) 0.77

The possibility of specific protection against bovine leukaemia virus infection and bovine leukaemia with inactivated BLV. Br Vet J (1983) 0.76

[Comparative study of the oligopeptide maps of virus-specific proteins of the viruses of the tick-borne encephalitis complex]. Vopr Virusol (1985) 0.76

[Antiproliferative effect of interferon inducers]. Vopr Virusol (1985) 0.76

[The structural and functional analysis of the biological activity of acridine derivatives]. Vestn Ross Akad Med Nauk (2004) 0.76

[Integration of virus genome with the genome of brain cells during tick-borne encephalitis with a progressive course]. Vestn Akad Med Nauk SSSR (1977) 0.76

Persistence of genes of epidemical influenza viruses in natural populations in the USSR. Med Biol (1983) 0.76

[Integration and transfection of an arbovirus by mammalian cells]. Mol Biol (Mosk) (1979) 0.76

[Role of natural cytotoxic lymphocytes (natural killers) in the pathogenesis of influenza]. Vopr Virusol (1988) 0.76

[Cycloferon administration in chronic pyelonephritis: changes in interferon status]. Ter Arkh (2011) 0.76

[Reconstruction of autonomic genetic and protein-synthesizing systems from viral RNA and isolated mitochondria]. Dokl Akad Nauk SSSR (1971) 0.76

[Experimental infection of monkeys caused by L-forms of group A streptococci. II. Acute experimental infection in monkeys]. Zh Mikrobiol Epidemiol Immunobiol (1972) 0.76

[Co-leukemogenic activity of protein preparations, isolated from cells of Mycoplasma arthritidis]. Vestn Akad Med Nauk SSSR (1985) 0.75

[The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers]. Ter Arkh (2014) 0.75

Reevaluation of the proteins in rabies virus particles. J Virol (1979) 0.75

Double-stranded complex of polyguanylic and polycytidylic acids and its antiviral activity in tissue culture. Acta Virol (1975) 0.75

[Protective effect of cycloferon in experimental influenza]. Vopr Virusol (2001) 0.75

[50 years of Soviet virology]. Vopr Virusol (1969) 0.75

Multiplication of measles virus in the presence of actinomycin D, aurantin or 5-bromodeoxyuridine. Acta Virol (1966) 0.75

[Ion-exchange chromatography of classical fowl plague virus on cellulose exchangers]. Vopr Virusol (1969) 0.75